Search results
U.S. FDA places hold on Biomea’s diabetes trial
WHTC 1450 Holland· 3 days ago(Reuters) - Biomea Fusion said on Thursday the U.S. Food and Drug Administration had placed a clinical hold on its ongoing early-to-mid stage study of...
FDA panel rejects psychedelic drug MDMA as a PTSD treatment - Maryland Daily Record
The Daily Record· 4 days agoA panel of advisers to the Food and Drug Administration voted 10-1 against the overall benefits of...
Video Shows Prominent Doctors Acknowledging, And Even Challenging, The Experimental Nature Of Sex...
IJR· 4 days agoThis is the first article in the “WPATH Tapes” series on the World Professional Association for Transgender Health and the gender medical industry. Internal training footage ...
U.S. FDA places clinical hold on Biomea's diabetes trials
AOL· 3 days agoThe drug, BMF-219, was being tested in an early-to-mid stage study for type 2 diabetes and a mid-stage study in type 1 diabetes. The drug developer said ...
The world's first drug that can regrow teeth has been approved for human trials this year
UNILAD· 5 days agoIn a significant breakthrough, the world's first drug that can regrow teeth has been approved for...
A weight loss drug maker's stock is rising on leaked clinical data
Quartz· 3 days agoZealand Pharma’s stock initially jumped 7% on Thursday, after results from a phase 2 clinical trial...
FDA advisers reject MDMA therapy to treat PTSD
FOX 10 Phoenix· 4 days agoLykos Therapeutics, the company behind the MDMA study, said it previously reported the incident to the FDA and regulators in Canada, where the therapist...
The Case for MDMA’s Approval Is Riddled With Problems
Wired News· 3 days agoIn medical research, a double-blinded placebo controlled trial—in which neither the participants nor...
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
KSL Salt Lake City· 5 days agoThe panel of advisers to the Food and Drug Administration sided 10-1 against the overall benefits of...